Prediction Market Investments Continue Despite Regulatory Uncertainty Earnings Calls Reveal Steady Commitment Torrent Pharma Reports 26 Drop in Q4 Profit Amid Acquisition Costs and QIP Approval SpaceX IPO Speculation Nvidia Earnings Bezos on AI Bubble Morning Market Digest How Big Tech Influenced Trumps Reversal on AI Safety Executive Order Jobless Claims Remain Near Historic Lows Amid Tight Labor Market Dating Startups Target Fake Profiles with Verification Services REVB Q1 2026 Earnings Significant EPS Miss as Cash Burn Continues Without Revenue DMRA Q1 2026 Earnings WiderthanExpected Loss but Stock Gains Amid Pipeline Optimism SCCO Q1 2026 Earnings Strong EPS Beat Highlights Operational Efficiency VolitionRX Limited VNRX Q1 2026 Earnings EPS Misses as Company Advances Diagnostic Pipeline Revvity Q1 2026 Earnings EPS Surpasses Consensus Stock Slips on Missing Revenue Details INVH Q1 2026 Earnings Strong EPS Surprise Amidst Stable Operations Abacus Global Management ABX Slides 25 as Selling Pressure Pushes Shares Toward Key Support Cardinal Infrastructure Group CDNL Dips 236 as Infrastructure Stocks Face SectorWide Headwinds Social Commerce Partners Warrant SCPQW Surges 133 as Investors Eye Key Resistance Level Tamboran Resources TBN Holds Firm Near Resistance as Energy Sector Stabilizes MaxCyte Inc MXCT Faces Selling Pressure Approaches Key Support at 095 Chinese Investors Turn to Dividend Stocks as Alternative Investment Options Shrink KTTA Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Stock Reaction Perdoceo Education PRDO Slips Slightly as Shares Approach Support Zone INVO Fertility IVF Gains 294 as Shares Approach Key Resistance Level Radian Group Inc RDN Declines Slightly as Shares Test Key Support Levels NMI Holdings Faces Modest Decline Support Levels in Focus for NMIH Silvercorp Metals SVM Slips 327 as Selling Pressure Intensifies SeaStar Medical ICU Declines 45 as Stock Approaches Critical Support Wheaton Precious Metals WPM Slips Slightly Amid Broad Market Uncertainty Key Levels in Focus Biodexa Pharmaceuticals BDRX Edges Higher as Stock Tests Key Resistance Levels